Trade Summary

2 days ago, Janku Filip, serving as Chief Medical Officer at Monte Rosa Therapeutics, Inc. (GLUE), sold 6,000 shares at $22.95 per share, for a total transaction value of $137,700.00. Following this transaction, Janku Filip now holds 59,992 shares of GLUE.

This sale represents a 9.09% decrease in Janku Filip's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 29, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 30, 2026 at 4:05 PM ET, 1 day after the trade was made.

Monte Rosa Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.